<![CDATA[Vifor Fresenius Medical Care Renal Pharma 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=34969>Wed, 08 Apr 2026 17:36:54 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)]]>https://www.newswire.co.kr/newsRead.php?no=949753Thu, 18 Aug 2022 16:40:00 +0900<![CDATA[VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)]]>https://www.newswire.co.kr/newsRead.php?no=916363Tue, 22 Dec 2020 10:26:50 +0900<![CDATA[VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus]]>https://www.newswire.co.kr/newsRead.php?no=904010Tue, 21 Apr 2020 16:32:26 +0900